Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
Department of Life Sciences, University of Trieste, Trieste, Italy.
Front Immunol. 2021 Aug 13;12:693118. doi: 10.3389/fimmu.2021.693118. eCollection 2021.
The complement system is a major component of humoral innate immunity, acting as a first line of defense against microbes opsonization and lysis of pathogens. However, novel roles of the complement system in inflammatory and immunological processes, including in cancer, are emerging. Endometriosis (EM), a benign disease characterized by ectopic endometrial implants, shows certain unique features of cancer, such as the capacity to invade surrounding tissues, and in severe cases, metastatic properties. A defective immune surveillance against autologous tissue deposited in the peritoneal cavity allows immune escape for endometriotic lesions. There is evidence that the glandular epithelial cells found in endometriotic implants produce and secrete the complement component C3. Here, we show, using immunofluorescence and RT-qPCR, the presence of locally synthesized C3 in the ectopic endometriotic tissue, but not in the eutopic tissue. We generated a murine model of EM injection of minced uterine tissue from a donor mouse into the peritoneum of recipient mice. The wild type mice showed greater amount of cyst formation in the peritoneum compared to C3 knock-out mice. Peritoneal washings from the wild type mice with EM showed more degranulated mast cells compared to C3 knock-out mice, consistent with higher C3a levels in the peritoneal fluid of EM patients. We provide evidence that C3a participates in an auto-amplifying loop leading to mast cell infiltration and activation, which is pathogenic in EM. Thus, C3 can be considered a marker of EM and its local synthesis can promote the engraftment of the endometriotic cysts.
补体系统是体液固有免疫的主要组成部分,作为抵御微生物的第一道防线,发挥调理作用并溶解病原体。然而,补体系统在炎症和免疫过程中的新作用,包括在癌症中的作用,正在不断涌现。子宫内膜异位症(EM)是一种以异位子宫内膜植入为特征的良性疾病,表现出某些癌症的独特特征,如侵袭周围组织的能力,在严重情况下还具有转移特性。针对腹腔内沉积的自体组织的免疫监视缺陷使子宫内膜异位病灶能够逃避免疫。有证据表明,在子宫内膜异位植入物中发现的腺上皮细胞产生并分泌补体成分 C3。在这里,我们通过免疫荧光和 RT-qPCR 显示,异位子宫内膜组织中存在局部合成的 C3,但在在位组织中不存在。我们建立了子宫内膜异位症的小鼠模型,即将供体小鼠的子宫组织切成小块注入受体小鼠的腹腔。与 C3 敲除小鼠相比,野生型小鼠的腹腔中形成的囊肿更多。与 C3 敲除小鼠相比,来自患有 EM 的野生型小鼠的腹腔冲洗液中显示出更多脱颗粒的肥大细胞,这与 EM 患者腹腔液中更高的 C3a 水平一致。我们提供的证据表明,C3a 参与了导致肥大细胞浸润和激活的自动放大环,这在 EM 中是致病的。因此,C3 可以被视为 EM 的标志物,其局部合成可以促进子宫内膜异位囊肿的植入。